| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.4 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |